Gemcitabine: In vitro and in vivo evidence of its radiation sensitizing activity and studies using fluorine-19 magnetic resonance spectroscopy to determine an optimal Gemcitabine dosing schedule - Pre-clinical observations relevant to Gemcitabine clinical trials.